Celyad Oncology (Celyad Oncology) Pre-Tax Income : $-15.19 Mil (TTM As of Jun. 2023)

Celyad Oncology Pre-Tax Income Chart

Celyad Oncology Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
Pre-Tax Income		Get a 7-Day Free Trial					-42.58	-31.82	-20.93	-29.95	-43.29

Celyad Oncology Quarterly Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
Pre-Tax Income	Get a 7-Day Free Trial															-4.82	-8.34	-6.85	-	-

Competitive Comparison of Celyad Oncology's Pre-Tax Income

For the Biotechnology subindustry, Celyad Oncology's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celyad Oncology's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celyad Oncology's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Celyad Oncology's Pre-Tax Income falls into.

Celyad Oncology Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Celyad Oncology's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Celyad Oncology's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-15.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celyad Oncology  (OTCPK:CYADY) Pre-Tax Income Explanation

Celyad Oncology's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

During the past 12 years, Celyad Oncology's highest Pretax Margin was -235.84%. The lowest was -970466.67%. And the median was -11269.18%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celyad Oncology Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Celyad Oncology's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Celyad Oncology (Celyad Oncology) Business Description